1st Quarter - Report
ADAPTIVE BIOTECHNOLOGIES for ADAPTIVE BIOTECHNOLOGIES
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA LYNN BRADLEY | covered legislative branch official |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.